Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.105
-0.005 (-0.45%)
May 19, 2025, 10:34 AM - Market open
Werewolf Therapeutics Stock Forecast
HOWL's stock price has decreased by -77.11% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Werewolf Therapeutics stock ranges from a low of $4.00 to a high of $15. The average analyst price target of $8.33 forecasts a 653.85% increase in the stock price over the next year.
Price Target: $8.33 (+653.85%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Werewolf Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +442.99% | May 9, 2025 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +623.98% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,257.47% | Mar 12, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $12 → $4 | Buy | Maintains | $12 → $4 | +261.99% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,257.47% | Nov 19, 2024 |
Financial Forecast
Revenue This Year
1.02M
from 1.89M
Decreased by -45.89%
Revenue Next Year
10.20M
from 1.02M
Increased by 900.00%
EPS This Year
-1.80
from -1.63
EPS Next Year
-1.54
from -1.80
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.3M | 52.5M | 24.4M | ||
| Avg | 1.0M | 10.2M | 5.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 234.2% | 5,047.1% | 138.8% | ||
| Avg | -45.9% | 900.0% | -42.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.73 | -0.85 | -1.63 | ||
| Avg | -1.80 | -1.54 | -1.71 | ||
| Low | -1.86 | -2.20 | -1.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.